# Nitronex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nitronex

- Industry: Semiconductors
- Headquarters: Durham, US
- Website: www.macom.com
- Total disclosed funding: $36M
- Latest round: Series C (Jul 22, 2003)
- Investors on record: 9

## About

Nitronex specializes in high-performance semiconductor solutions, primarily focusing on RF, microwave, and optical networking applications to meet the demands of sectors such as aerospace, defense, and telecommunications.Nitronex, founded in 1999 in Durham, US, operates under the umbrella of Gaas Labs, which acquired the company in June 2012 for an undisclosed sum. The firm has completed a total of 14 deals since its inception, with a notable funding round being the Venture Debt of USD 4.50 mn, contributing to a total amount raised of USD 19.40 mn.Nitronex, through its parent company MACOM Technology Solutions Inc., designs and manufactures high-performance semiconductor solutions tailored for RF, microwave, and optical networking applications. Key offerings include RF power amplifiers, low noise amplifiers (LNAs), and optical components such as lasers and transceivers, which serve critical roles in aerospace and defense, satellite communications, and data center infrastructures. Their OPTO-AMP™ high power optical amplifier enhances communication between satellites and ground networks, addressing the global demand for advanced communication technologies.Nitronex primarily generates revenue through direct sales of semiconductor products to a diverse clientele, including aerospace and defense contractors, telecommunications providers, and data center operators. Client transactions are typically B2B, involving products like RF power pallets and high-speed optical modules. The pricing structure is customized based on product complexity and application, often through contractual agreements that foster long-term partnerships, inclusive of volume discounts and tailored solutions.Nitronex is poised for growth with plans for new product designs in optical networking to be launched in the next fiscal year. The company is targeting expansions into European and Asian markets by 2025, leveraging its recent Venture Debt funding of USD 4.50 mn to support these initiatives and enhance product development capabilities.

## Funding rounds

- Series C, Jul 22, 2003, $11M — VantagePoint Capital, Alliance Technology Ventures, TPG Biotech
- Series B, Jul 13, 2001, $25M — TPG, VantagePoint Capital, Southeast Interactive Technology Funds, Contender Investments, Alliance Technology Ventures, Centennial, Boston University Community Technology Fund
- Series A, May 1, 2000 — Centennial Ventures, TPG, VantagePoint Capital, Southeast Interactive Technology Funds, Contender Investments, Alliance Technology Ventures, Boston University Community Technology Fund

## Investors

- Centennial Ventures (https://capitalatlas.ai/funds/centennial-ventures) — Series A
- TPG (https://capitalatlas.ai/funds/tpg) — Series A, Series B
- VantagePoint Capital (https://capitalatlas.ai/funds/vantagepoint-capital) — Series A, Series B, Series C
- Southeast Interactive Technology Funds (https://capitalatlas.ai/funds/southeast-interactive-technology-funds) — Series A, Series B
- Contender Investments (https://capitalatlas.ai/funds/contender-investments) — Series A, Series B
- Alliance Technology Ventures (https://capitalatlas.ai/funds/alliance-technology-ventures) — Series A, Series B, Series C
- Boston University Community Technology Fund — Series A, Series B
- Centennial — Series B
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series C